Simultaneously, the formation of VM was associated with anti-VEGF treatment resistance, and the combination treatment with anti-VEGF antibody and γ-secretase inhibitor DAPT, which can inhibit the Notch signaling, significantly restrained the growth of lung cancer [114]. This evidence concerns the gene VEGFA and lung carcinoma.